ATE293439T1 - Verfahren und system zur gleichmä igen arzneistoffabgabe - Google Patents
Verfahren und system zur gleichmä igen arzneistoffabgabeInfo
- Publication number
- ATE293439T1 ATE293439T1 AT01128075T AT01128075T ATE293439T1 AT E293439 T1 ATE293439 T1 AT E293439T1 AT 01128075 T AT01128075 T AT 01128075T AT 01128075 T AT01128075 T AT 01128075T AT E293439 T1 ATE293439 T1 AT E293439T1
- Authority
- AT
- Austria
- Prior art keywords
- agent
- core
- release
- drugs
- even delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25199600P | 2000-12-07 | 2000-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE293439T1 true ATE293439T1 (de) | 2005-05-15 |
Family
ID=22954223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01128075T ATE293439T1 (de) | 2000-12-07 | 2001-11-27 | Verfahren und system zur gleichmä igen arzneistoffabgabe |
Country Status (9)
Country | Link |
---|---|
US (1) | US20020119197A1 (de) |
EP (1) | EP1213014B1 (de) |
JP (1) | JP2002212061A (de) |
AT (1) | ATE293439T1 (de) |
BR (1) | BR0105909A (de) |
CA (1) | CA2363902C (de) |
DE (1) | DE60110192T2 (de) |
ES (1) | ES2240313T3 (de) |
MX (1) | MXPA01012456A (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US20040253310A1 (en) | 2001-09-21 | 2004-12-16 | Gina Fischer | Morphine polymer release system |
US20040234602A1 (en) | 2001-09-21 | 2004-11-25 | Gina Fischer | Polymer release system |
US8871241B2 (en) * | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
BR0309844A (pt) * | 2002-05-07 | 2005-02-15 | Control Delivery Sys Inc | Processos para formação de um dispositivo para a distribuição de droga |
US8877241B2 (en) | 2003-03-26 | 2014-11-04 | Egalet Ltd. | Morphine controlled release system |
WO2004093819A2 (en) | 2003-04-21 | 2004-11-04 | Euro-Celtique, S.A. | Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same |
JP4917893B2 (ja) * | 2003-12-09 | 2012-04-18 | ユーロ−セルティーク エス.エイ. | 作用薬及び逆作用薬を含有する不正使用防止共押出剤型、及びその製造方法 |
AT500144A1 (de) * | 2004-03-05 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung |
KR101053558B1 (ko) | 2004-03-30 | 2011-08-03 | 유로-셀띠끄 소시에떼 아노님 | 흡착제 및 억제제를 포함하는 내변조성 제형 |
JP2008521878A (ja) * | 2004-12-02 | 2008-06-26 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 非晶質アトルバスタチンの医薬組成物及びその製造のための方法 |
US20070249673A1 (en) * | 2006-04-20 | 2007-10-25 | Angelika Bodenteich | Method for administering tolperisone |
EP1859788A1 (de) * | 2006-05-24 | 2007-11-28 | Abbott GmbH & Co. KG | Herstellung von umhüllten pharmazeutischen Darreichungsformen |
DE102006033723A1 (de) * | 2006-07-21 | 2008-01-24 | Bayer Technology Services Gmbh | Formulierungen von Multikompartimenten-Granulaten für Wirkstoffe |
US8821928B2 (en) | 2007-06-04 | 2014-09-02 | Egalet Ltd. | Controlled release pharmaceutical compositions for prolonged effect |
EP2543691A3 (de) * | 2007-09-28 | 2013-10-30 | Dow Global Technologies LLC | Herstellungverfahren für ein Langfaserkonzentrat mit Dispersion aus Olefin mit höherer Kristallinität |
EP2393487B1 (de) | 2009-02-06 | 2016-11-02 | Egalet Ltd. | Gegen missbrauch resistente pharmazeutische zusammensetzungen |
US9005660B2 (en) | 2009-02-06 | 2015-04-14 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
WO2010149169A2 (en) | 2009-06-24 | 2010-12-29 | Egalet A/S | Controlled release formulations |
SG10201504529WA (en) * | 2010-03-09 | 2015-07-30 | Alkermes Pharma Ireland Ltd | Alcohol Resistant Enteric Pharmaceutical Compositions |
CN103068375B (zh) * | 2010-08-18 | 2017-02-15 | 麦克内尔-Ppc股份有限公司 | 改善性能的片剂套管 |
EP2651399A2 (de) | 2010-12-13 | 2013-10-23 | Purdue Pharma LP | Retard-darreichungsformen |
CA2877183A1 (en) | 2012-07-06 | 2014-01-09 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
BR112016025045A2 (pt) * | 2014-05-30 | 2017-08-15 | Textile Based Delivery Inc | sistema de distribuição de fármaco e método de distribuição de um composto biologicamente ativo |
MX2017005399A (es) | 2014-10-30 | 2017-07-26 | Textile-Based Delivery Inc | Sistemas de administracion. |
CN109475510B (zh) | 2016-07-17 | 2023-03-10 | Mapi医药公司 | 普瑞巴林的延长释放剂型 |
CN113456626B (zh) * | 2021-08-16 | 2022-05-06 | 吉林大学 | 一种黄嘌呤氧化酶抑制剂及其筛选方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3432689A (en) * | 1988-03-24 | 1989-10-16 | Bukh Meditec A/S | Controlled release composition |
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
WO1992005776A1 (en) * | 1990-10-01 | 1992-04-16 | The Upjohn Company | Lateral edge coated controlled release pharmaceutical compositions |
JP4194114B2 (ja) * | 1994-02-23 | 2008-12-10 | ビーエム リサーチ エイ/エス | 制御放出組成物 |
FR2766088B1 (fr) * | 1997-07-17 | 2001-01-05 | Dow Corning Sa | Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire |
HN1998000115A (es) * | 1997-08-21 | 1999-06-02 | Warner Lambert Co | Formas de dosificación farmacéuticas sólidas |
-
2001
- 2001-11-27 ES ES01128075T patent/ES2240313T3/es not_active Expired - Lifetime
- 2001-11-27 DE DE60110192T patent/DE60110192T2/de not_active Expired - Fee Related
- 2001-11-27 EP EP01128075A patent/EP1213014B1/de not_active Expired - Lifetime
- 2001-11-27 AT AT01128075T patent/ATE293439T1/de not_active IP Right Cessation
- 2001-11-27 CA CA002363902A patent/CA2363902C/en not_active Expired - Fee Related
- 2001-12-03 MX MXPA01012456A patent/MXPA01012456A/es unknown
- 2001-12-05 US US10/007,177 patent/US20020119197A1/en not_active Abandoned
- 2001-12-06 JP JP2001372492A patent/JP2002212061A/ja active Pending
- 2001-12-06 BR BR0105909-2A patent/BR0105909A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1213014A3 (de) | 2002-07-03 |
EP1213014B1 (de) | 2005-04-20 |
JP2002212061A (ja) | 2002-07-31 |
US20020119197A1 (en) | 2002-08-29 |
DE60110192D1 (de) | 2005-05-25 |
DE60110192T2 (de) | 2006-03-09 |
BR0105909A (pt) | 2002-08-13 |
MXPA01012456A (es) | 2005-06-30 |
ES2240313T3 (es) | 2005-10-16 |
CA2363902A1 (en) | 2002-06-07 |
CA2363902C (en) | 2005-07-26 |
EP1213014A2 (de) | 2002-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE293439T1 (de) | Verfahren und system zur gleichmä igen arzneistoffabgabe | |
ATE366104T1 (de) | Verfahren zur herstellung von in der mundhöhle rasch zerfallenden tabletten | |
BRPI0409652A (pt) | tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete | |
DE59104172D1 (de) | Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren. | |
DE60329298D1 (de) | Polymerisierbare zusammensetzung, die zusammensetzung enthaltendes optisches material und verfahren zur herstellung des materials | |
ATE136459T1 (de) | Verfahren zur herstellung retardierter arzneimittelzubereitungen | |
FR2679450B1 (fr) | Procede pour la preparation de microspheres en matiere polymere biodegradable, pour la liberation controlee de substances medicamenteuses peptidiques. | |
ATE508725T1 (de) | Verfahren zur herstellung von tabletten | |
DE69935330D1 (de) | Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen | |
ATE406889T1 (de) | Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin | |
HUP0401079A2 (hu) | Nulladrendű, nulladrendű-kétfázisú, időben emelkedő és csökkenő gyógyszerszállításra szolgáló gyógyszerszállító rendszer | |
NO960067D0 (no) | Nytt farmasöytisk preparat | |
ATE348607T1 (de) | Verfahren und pharmazeutische zusammensetzung zur regelung der lipidkonzentration | |
ATE243193T1 (de) | Benzocycloheptene, verfahren zu ihrer herstellung,pharmazeutische präparate die diese enthalten sowie deren verwendung zur herstellung von arzneimitteln | |
DE69017307D1 (de) | Verfahren zur Bilderzeugung aus Zusammensetzungen mit thermisch koaleszierenden Materialien. | |
DZ2923A1 (fr) | Formulations pharmaceutiques d'inhibiteurs de pde-5 de gmpc à libération contrôlée, et procédé pour leur préparation. | |
ATE442852T1 (de) | Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung | |
AR018609A1 (es) | Composicion farmaceutica solida estabilizada que contiene un derivado de acido 4-amino-3-sustituido-butanoico y proceso para su preparacion. | |
DE59908764D1 (de) | Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung | |
DE60301570D1 (de) | 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
ES2173194T3 (es) | Procedimiento de racemizacion utilizado para la preparacion de levobupivacaina y sus analogos. | |
DE59608606D1 (de) | Cyclosprorin(e) enthaltende pharmazeutische zubereitung zur oralen applikation und verfahren zu ihrer herstellung | |
DE60202603D1 (de) | 8-(c-beta-d-glucopyranosyl)-7,3',4'-trihydroxyflavone, verfahren zur isolation aus pterocarpus marsupium und pharmazeutische zusammensetzung zur behandlung von diabetes | |
DK1267833T3 (da) | Farmaceutiske præparater og fremgangsmåde til fremstilling deraf | |
DE69617435D1 (de) | Absorbierendes material, formkörper aus diesem material und verfahren zur herstellung des materials. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |